- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
5
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$337.28 | -2.5% | 8.2% | US$10.4b | US$347.92 | PE28.6x | E10.8% | n/a | ||
PTGX | US$41.49 | 1.0% | 86.6% | US$2.4b | US$57.50 | PE14.5x | E-36.0% | n/a | ||
AGIO | US$35.42 | -9.1% | 48.0% | US$2.0b | US$57.29 | PE3x | E-57.3% | n/a | ||
MDXG | US$9.10 | -0.7% | 2.2% | US$1.3b | US$13.40 | PE16.8x | E-1.9% | n/a | ||
SCNI | US$3.40 | -0.6% | -50.2% | US$2.9m | n/a | PE0.6x | n/a | n/a |
Page 1 of 1